Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod

Pfizer (PFE) announced that the European Commission has granted marketing approval to its oral, once-daily pill called Velsipity (etrasimod) to treat moderately to severely active ulcerative colitis (UC).The approval for the oral, once-daily, selective sphingosine-1-phosphate (S1P) receptor modulator (2 mg dose) is for UC patients who are 16 years of age and older and who have had an inadequate response, lost response, or were intolerant to either conventional therapy or injectable therapies like biologics. ...